StonvexLoading…
StonvexStonvexStonvexCore line items from HUBS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $881.00M | $3.13B | $2.28B | $1.48B |
Operating Income | $27.94M | $7.38M | $-40.86M | $-52.10M |
Net Income | $32.55M | $45.91M | $-8.52M | $-3.26M |
EPS (Diluted) | $0.62 | $0.86 | $-0.16 | $-0.48 |
Total Assets | $3.83B | $3.85B | $3.50B | $3.68B |
Total Liabilities | $1.83B | $1.79B | $1.65B | $1.62B |
Cash & Equivalents | $943.94M | $882.24M | $614.35M | $601.20M |
Free Cash Flow OCF − CapEx | $183.40M | $707.55M | $473.57M | $296.56M |
Shares Outstanding | 51.95M | 52.55M | 52.22M | 52.70M |